Seamless Transitions: Supporting Patients Through Treatment, Monitoring, and Maintenance

Panelists discuss how industry-provided patient support services can assist patients receiving bispecific antibodies, particularly in monitoring and follow-up care, and how these services can support patients transitioning from active treatment to maintenance or posttreatment care.

EP: 1.Challenges at Diagnosis: Navigating the Emotional and Physical Realities of DLBCL and FL

EP: 2.Empowering Patients: Strategies for Emotional Resilience and Support in Lymphoma Care

EP: 3.Tailored Support: The Role of Industry-Provided Services in Lymphoma Care

Now Viewing

EP: 4.Seamless Transitions: Supporting Patients Through Treatment, Monitoring, and Maintenance

EP: 5.Innovations and Impact: The Future of Patient Support Services in Hematology-Oncology

Video content above is prompted by the following:

What role would these services play in assisting patients receiving bispecific antibodies, particularly regarding monitoring and follow-up care to ensure optimal outcomes?
How can industry-provided patient support services help patients transition from active treatment to maintenance or posttreatment care?